Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Bridging the Gap: New Bipartisan Legislative Push Targets Substance Use Recovery and Treatment Infrastructure on October 24, 2026 Posted by
The Future of Healing: CRI’s 2026 Gala Spotlights the "Next is Now" Era of Immunotherapy on October 24, 2026 Posted by
The Invisible Obstacle: How Fluid Viscosity Fuels Glioblastoma Aggression on October 24, 2026 Posted by
Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Posted in Digital Health Tools Medtronic’s Strategic Pivot: Inside the $650 Million Acquisition of SPR Therapeutics on July 18, 2026
Posted in Medical Innovations Jasper Therapeutics Secures Financial Lifeline Through Strategic Merger with Kira Pharmaceuticals on July 17, 2026
Posted in Sleep Health New Frontiers in Neuropsychopharmacology: Addex Therapeutics’ Breakthrough in mGlu7 Receptor Modulation on July 15, 2026
Posted in Medical Innovations Avere Therapeutics Enters the Immunology Arena: A Strategic Pivot via Reverse Merger and Chinese Innovation on July 15, 2026
Posted in Cancer Recovery Pioneering Precision: Dr. Thomas Corner’s Quest to Redefine Lymphoma Therapeutics on July 11, 2026
Posted in Medical Innovations A New Era in Nephrology: FDA Grants Accelerated Approval to Vera Therapeutics’ Trutakna for IgA Nephropathy on July 9, 2026
Posted in Digital Health Tools A New Frontier in Nephrology: FDA Grants Accelerated Approval to Vera Therapeutics’ Trutakna for IgA Nephropathy on July 9, 2026
Posted in Cancer Recovery Mining the Tumor Microbiome: A New Frontier in Cancer Therapeutics on July 8, 2026
Posted in Medical Innovations Scribe Therapeutics Eyes Nasdaq IPO: A High-Stakes Bet on the Future of Genetic Medicine on July 6, 2026
Posted in Digital Health Tools Celea Therapeutics Secures $180 Million to Challenge the Status Quo in IPF Treatment on July 5, 2026
